A compounding Pharmacy is referred to a pharmacy run by a licensed pharmacist, licensed physician, or an individual under the guidance of a licensed pharmacist. It is slightly dissimilar from a traditional pharmacy. However, the major role of a compounding pharmacy is to develop drugs that a physician prescribes as per the patient-specific requirement. It is making a custom formulation of a medication that suits a patient's unique requirement, which cannot be fulfilled with commercially available products. The rising elderly population and increasing life expectancy have fostered the adoption rate of customized medicines worldwide. The market for Compounding Pharmacies is anticipated to boom, owing to the increasing aging baby boomers population in requirement of personalized medications due to the rising incidents of chronic diseases among this population. Moreover, the rising patent expiries are one of the key growth propellant factors in the compounding pharmacy market. The high cost of maintaining the sterile environment and the absence of efficient regulations in several regions may hinder the market. The Compounding Pharmacy Market is anticipated to grow at the rate of 6.2% CAGR by 2026.   

Research Methodology:

The Compounding Pharmacy Market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology and a unique balance of primary insights. The real-time valuation of the market is an integral part of our forecasting and market sizing methodology. Industry experts and our primary participants have helped to compile related aspects with accurate parametric estimations for a complete study. The primary participants share is given below:

Compounding Pharmacy Market based on Therapeutic Areas

• Hormone Replacement
• Pain Management
• Dermatology Applications
• Specialty Drugs
• Nutritional Supplements

Compounding Pharmacy Market based on Products

• Oral
• Topical
• Parenteral
• Nasal
• Others

Compounding Pharmacy Market based on Compounding Types

• Pharmaceutical Ingredient Alteration
• Currently Unavailable Pharmaceutical Manufacturing
• Pharmaceutical Dosage Alteration

Compounding Pharmacy Market based on Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

In the compounding pharmacies market based on therapeutic areas, hormone replacement therapy achieves popularity in balancing hormones in the body. The upsurge in the number of people has exhibited a positive inclination towards hormone replacement therapy. The demand for compounded drugs is due to their rising application in the treatment, such as to treat several conditions, specifically in women, including irregular menstrual cycle, pre-menstrual syndrome, weight gain, and other conditions.

As per the compound types, the pharmaceutical dosage alteration segment has the largest share in the compounding pharmacies market. The senior population experiencing pain because of chronic diseases generally requires compounded drugs customized based on the patient’s requirement. Other allopathic drugs cause adverse reactions in old individuals suffering from chronic diseases that surge the compounded drugs' demand.

Based on the products, the oral segment held a substantial share in the compounding pharmacies market due to the growing demand from patients for oral medications because of ease of administration and transportation.

Geographically, the North American region is anticipated for the large share of the market and is likely to continue its domination during the forecasted period due to the senior population's growth, scarcity of drugs, and high healthcare awareness among the public. Moreover, the increasing government initiatives favor the compounding pharmacies and the existence of advanced healthcare infrastructure facilities in this region.

The world is facing a rapid shortage of drugs, which has caused problems for health care facilities, clinicians, patients, and federal regulators. Problems in production, acquisition of raw materials, regulatory issues and business arrangements, and interruptions in the supply chain are the key factors causing drug shortage. Healthcare professionals, mainly pharmacists and drug manufacturers, are constantly working on managing the shortage of drugs. Health care professionals have started formulating solutions to control drug shortages. Hence, compounding pharmacies are considered a viable source of drugs that are in short supply.

Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd, PharMEDium Healthcare Holdings, Inc., Fresenius Kabi AG, Elixir Compounding Pharmacy, Avella specialty pharmacy, B. Braun Melsungen AG, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy, Fagron, Inc., and US Compounding Inc are some of the competitors that are dominating the compounding pharmacy market.

Therefore, compounding pharmacies have a prominent role in offering access to discontinued medications by reproducing pharmaceutical-based ingredients to ensure that patients get the critical care they need. Presently, compounding pharmacies can access superior quality pharmaceutical ingredients and fill the prescription using the latest research.

• To examine and analyze the compounding pharmacy market size by key regions, therapeutic areas, products, and compound type.
• To understand the structure of the compounding pharmacy market by recognizing its various sub-segments.
• Emphasizes the key global compounding pharmacy competitors, defining, describing, and analyzing the market competition landscape, market share, value, SWOT analysis, and development plans in the next few years.
• To analyze the compounding pharmacy market in terms of individual growth trends, prospects, and contributions to the whole market.

1. Executive Summary
2. Industry Outlook
   1. Industry Overview
   2. Industry Trends
3. Market Snapshot
   1. Market Definition
   2. Market Outlook
      1. Porter Five Forces
   3. Related Markets
4. Market characteristics
   1. Market Overview
   2. Market Segmentation
   3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
   4. DRO - Impact Analysis
5. Therapeutic Areas: Market Size & Analysis
   1. Overview
   2. Hormone Replacement
   3. Pain Management
   4. Dermatology Applications
   5. Specialty Drugs
   6. Nutritional Supplements
6. Products: Market Size & Analysis
   1. Overview
   2. Oral
   3. Topical
   4. Parenteral
   5. Nasal
   6. Others
7. Compounding Types: Market Size & Analysis
   1. Overview
   2. Pharmaceutical Ingredient Alteration
   3. Currently Unavailable Pharmaceutical Manufacturing
   4. Pharmaceutical Dosage Alteration
8. Geography: Market Size & Analysis
   1. Overview
   2. North America
   3. Europe
   4. Asia Pacific
   5. Rest of the World
9. Competitive Landscape
   1. Competitor Comparison Analysis
   2. Market Developments
      1. Mergers and Acquisitions, Legal, Awards, Partnerships
      2. Product Launches and execution
10. Vendor Profiles
    1. Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    2. PharMEDium Healthcare Holdings, Inc.
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    3. Fresenius Kabi AG
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    4. Elixir Compounding Pharmacy
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    5. Avella specialty pharmacy
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    6. B. Braun Melsungen AG
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    7. Triangle Compounding Pharmacy
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    8. Vertisis Custom Pharmacy
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    9. Fagron, Inc.
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    10. US Compounding Inc
        1. Overview
        2. Financial Overview
        3. Product Offerings
        4. Developments
        5. Business Strategy
11. Analyst Opinion
12. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
       1. Data Collation and In-house Estimation
       2. Market Triangulation
       3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations